Medisun Holdings Limited, with its headquarters in Hong Kong, is a global professional medical investment group that focuses on investing in research, development and commercialization of regenerative medicine and top-tier hospitals and medical centers. Medisun has invested in Cardio3 BioSciences, a Belgian and French stock exchange-listed biotechnology company. Medisun is also actively engaged in clinical development of regenerative therapies in the United States, Japan, Hong Kong and China.
Medisun Laboratory operates 24hrs/day, 7days/week. The laboratory equipped with high-volume analytical equipment for extensive testing and rapid results to support a variety of clinical trials, meeting regulatory expectations, and the needs of researchers and industry.
Address: 25/F, OCTA Tower, 8 Lam Chak Street, Kowloon Bay, Hong Kong
Tel: (852) 2582 0188
Fax: (852) 2582 0199
Email: info@medisun.hk
